Ex-Receptos team snags another big round at Gossamer

Gossamer Bio Inc. (San Diego, Calif.) raised $230 million in an untranched series B round led by new investor Hillhouse Capital, bringing the biotech's total funding to $330 million since its January launch. Also participating in

Read the full 364 word article

User Sign In